Iron-deficiency Clinical Trial
Official title:
Probing the Synergistic Effect of Pre-Biotics & Iron Fortificants in Anemic
Hypothesis: Synergistic effect of pre-biotics and iron fortificants will enhance the
bioavailability of iron; thereby improving the body iron reserves.
A double blind, randomized controlled trail will be conducted on iron deficient female adults
(age 18-25 years) in order to determine the synergistic effect of pre-biotics and iron
fortificants in anemic human subjects. 75 iron deficient females will be randomly divided
into 5 groups (D0, D1, D2, D3 and D4), each having 15 study subjects and will be given
varying doses of FeSO4 and NaFeEDTA and Inulin and GOS. Blood samples will be collected from
overnight fasted women from each group on monthly basis up to three months. Various
biomarkers for iron absorption, LFTs, RFTs, and Immunoglobulins will be estimated.
Study Design A double blind, randomized controlled trial will be used for the purpose of this
study.
Study Site The study will be conducted in Islamabad and/or Lahore, depending on the
availability of the required sample size with the desired profiles.
Study Duration The trial will last for 12 weeks. Study Population The study population will
consist of university going iron deficient female adults (age 18-25 years).
Inclusion and Exclusion Criteria Inclusion Criteria All willing anemic female adults without
any chronic diseases such as diabetes or hypertension will be included in the study.
Exclusion Criteria Married females or those with chronic diseases or those already taking
iron and/or prebiotic supplements will be excluded from the study.
Sampling Sampling Technique The technique of convenience sampling will be used for the
current study. Sample Size Each group will consist of 15 study subjects for the purpose of
convenience and the total sample size will be 75.
Treatment Plan For this phase of the study, 4 best treatment combinations of pre-biotics
(Inulin & Galactooligosaccharides) and iron fortificants (FeSO4 and NaFeEDTA) will be chosen.
Study participants will be randomly chosen to receive either the best treatment combination
1, 2, 3, 4 or the placebo for 12 weeks on daily basis.
Efficacy Trials Blood samples will be collected from overnight fasted women from each group
on monthly basis up to three months. Hematological analysis The collected blood from
respective groups will be assessed for hematological analysis.
Iron Biomarkers Obtained sera will also be analyzed for blood serum biomarkers like serum
iron, folate, ferritin, transferrin saturation fraction & TIBC.
Liver function tests Liver function tests including AST (Aspartate Aminotransferase), ALT
(Alanine Aminotransferase), ALP (Alkaline Phosphatase) and Total Bilirubin will be conducted
Renal function tests Blood urea (GLDH-method) and creatinine (Jaffe-method) levels will be
determined using commercial kits.
Immunoglobulins Immunoglobulins, including Immunoglobulin A, Immunoglobulin E, Immunoglobulin
G, and Immunoglobulin M will be determined using the technique of ELISA (Enzyme linked
Immunosorbent Assay).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04949165 -
Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study
|
N/A | |
| Terminated |
NCT03218384 -
Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency
|
Phase 2 | |
| Active, not recruiting |
NCT03516734 -
Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh
|
N/A | |
| Completed |
NCT03572010 -
Stable Iron Isotope Method in HIV+ and HIV- Children
|
N/A | |
| Active, not recruiting |
NCT03703726 -
Iron Absorption From Fortified Extruded Rice Using Different Extruding Temperatures.
|
N/A | |
| Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
| Not yet recruiting |
NCT05395468 -
Diagnosis of Iron Deficiency by Artificial Intelligence Analysis of Eye Photography.
|
||
| Withdrawn |
NCT03800446 -
Validation of a Point-of-care Device Measuring Ferritin With Capillary Blood
|
N/A | |
| Not yet recruiting |
NCT03353662 -
Sub Regional Micronutrient Survey in Ethiopia
|
||
| Completed |
NCT03819530 -
Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study
|
N/A | |
| Recruiting |
NCT04144790 -
Impact of Iron Supplementation Treatment on Brain Iron Concentrations
|
||
| Completed |
NCT03957057 -
Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia
|
Phase 3 | |
| Completed |
NCT03642223 -
Central and Peripheral Adiposity and Iron Absorption
|
N/A | |
| Not yet recruiting |
NCT05407987 -
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
|
Phase 3 | |
| Withdrawn |
NCT03873584 -
Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
|
||
| Enrolling by invitation |
NCT03897673 -
Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas
|
N/A | |
| Completed |
NCT04359368 -
Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions
|
||
| Active, not recruiting |
NCT04778072 -
A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects
|
N/A | |
| Enrolling by invitation |
NCT05750940 -
Oxidative Skeletal Muscle Metabolism in Chronic Heart Failure Patients With and Without Iron Deficiency
|
||
| Recruiting |
NCT05126901 -
Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
|
Phase 3 |